Hims is in the crosshairs. Is a crackdown coming for compounding? - statnews.com
AI Summary1 min read
TL;DR
Novo Nordisk is suing Hims & Hers for allegedly copying its Wegovy weight loss drugs, causing Hims' stock to drop significantly and forcing it to delay its own weight loss pill launch amid FDA scrutiny.
Tags
HimsNovo NordiskWegovypatent lawsuitweight loss drugs
- Hims is in the crosshairs. Is a crackdown coming for compounding? statnews.com
- Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock falls 18% CNBC
- Hims retreats from weight loss pill launch as Novo, FDA pressure mounts Fierce Pharma
- Novo Nordisk opens new front with patent suit over Hims’ Wegovy copies Reuters
- HIMS Dips 55.8% in 3 Months: Should You Still Hold the Stock or Sell? Yahoo Finance